Zhengya Gao
University of Florida(US)Florida College(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Bone Tumor Diagnosis and Treatments, Surgical site infection prevention, Testicular diseases and treatments, CAR-T cell therapy research
Most-Cited Works
- → Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group(2022)49 cited
- → Outcomes After Preoperative Chemoradiation With or Without Pazopanib in Non-Rhabdomyosarcoma Soft Tissue Sarcoma: A Report From Children's Oncology Group and NRG Oncology(2023)27 cited
- → Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group(2023)10 cited
- → Outcomes following preoperative chemoradiation +/- pazopanib in non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): A report from Children's Oncology Group (COG) and NRG Oncology.(2022)8 cited
- → Event‐free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group(2024)7 cited
- → Management and outcomes of chest wall rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee(2023)7 cited
- → Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials: A report from the Children's Oncology Group(2023)6 cited
- → Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children’s Oncology Group study ARST0332(2024)6 cited
- → Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: A Report From the Children's Oncology Group(2025)1 cited
- → Racial and ethnic differences in presentation and clinical outcomes for pediatric rhabdomyosarcoma (RMS).(2022)